Characterization of novel endo-β-N-acetylglucosaminidase from Bacteroides nordii that hydrolyzes multi-branched complex type N-glycans.


Journal

Journal of bioscience and bioengineering
ISSN: 1347-4421
Titre abrégé: J Biosci Bioeng
Pays: Japan
ID NLM: 100888800

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 01 02 2022
revised: 27 03 2022
accepted: 28 03 2022
pubmed: 29 4 2022
medline: 22 6 2022
entrez: 28 4 2022
Statut: ppublish

Résumé

Endo-β-N-acetylglucosaminidases (ENGases) are enzymes that hydrolyze the N-linked oligosaccharides. Many ENGases have already been identified and characterized. However, there are still a few enzymes that have hydrolytic activity toward multibranched complex-type N-glycans on glycoproteins. In this study, one novel ENGase from Bacteroides nordii (Endo-BN) species was identified and characterized. The recombinant protein was prepared and expressed in Escherichia coli cells. This Endo-BN exhibited optimum hydrolytic activity at pH 4.0. High performance liquid chromatography (HPLC) analysis showed that Endo-BN preferred core-fucosylated complex-type N-glycans, with galactose or α2,6-linked sialic acid residues at their non-reducing ends. The hydrolytic activities of Endo-BN were also tested on different glycoproteins from high-mannose type to complex-type oligosaccharides. The reaction with human transferrin, fetuin, and α1-acid glycoprotein subsequently showed that Endo-BN is capable of releasing multi-branched complex-type N-glycans from these glycoproteins.

Identifiants

pubmed: 35484013
pii: S1389-1723(22)00089-5
doi: 10.1016/j.jbiosc.2022.03.011
pii:
doi:

Substances chimiques

Glycoproteins 0
Oligosaccharides 0
Polysaccharides 0
Acetylglucosaminidase EC 3.2.1.52
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase EC 3.2.1.96

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-13

Informations de copyright

Copyright © 2022 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Auteurs

Kristina Mae Bienes (KM)

Laboratory of Applied Microbiology, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Feunai Agape Papalii Tautau (FAP)

Laboratory of Applied Microbiology, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Ai Mitani (A)

Fushimi Pharmaceutical Co. Ltd., Marugame, Kagawa 763-8605, Japan.

Takashi Kinoshita (T)

Fushimi Pharmaceutical Co. Ltd., Marugame, Kagawa 763-8605, Japan.

Shin-Ichi Nakakita (SI)

Life Science Research Center, Kagawa University, Kagawa 761-0701, Japan.

Yujiro Higuchi (Y)

Laboratory of Applied Microbiology, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Kaoru Takegawa (K)

Laboratory of Applied Microbiology, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan. Electronic address: takegawa@agr.kyushu-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH